Sunshine Biopharma Shares Rise 26% After Patent Application for MRNA Molecules – MarketWatch

25th April 2022

Sunshine Biopharma Shares Rise 26% After Patent Application for MRNA Molecules MarketWatch

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

Filed, Not Forgotten: FTC Signals Antitrust Scrutiny of Patent Application Acquisitions in Biologic Drug Markets - Crowell & Moring LLP
Solvonis Therapeutics wins key European patent for PTSD drug candidate SVN-114 - pluang.com
Solvonis Therapeutics secures key European patent for PTSD drug candidate - Yahoo! Finance Canada
White & Brief strengthens IP, Tech & Media practice by roping in three-Partner team from ANM Global led by Rahul Dhote - Bar and Bench

UK BUSINESS NEWS…

Free travel pilot scheme for young people approved
How much should you give towards a leaving gift?
How much should you give towards a leaving gift?
Almost half of households do not see benefits of economic growth, report says

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION